There has been little information on the clinical course and response to treatment in HCL-V. Preliminary data suggest that HCL-V patients do not respond well to the treatments useful in typical HCL.4.5 Thus, it is important to define more precisely the diagnostic criteria of this variant form. We describe here the clinical and laboratory features of a relatively large series of HCL-V patients and compare this information with that of other B-cell leukemias evolving with splenomegaly: HCL, B-PLL, and splenic lymphoma with circulating villous lymphocytes (SLVL).3
A was first described by Cawley et al' in 1980 . HCL-V is an uncommon disorder that is sometimes difficult to distinguish from other B-cell lymphoproliferative disorders.2 The first cases reported had distinctive features by comparison with classic HCL: chronic course without infections, a high leukocyte count without neutropenia or monocytopenia, and an easily aspirable bone marrow. The lymphoid cells had a B-cell phenotype and morphologically closely resembled hairy cells, showing numerous surface projections. However, they differed from typical hairy cells by having a prominent nucleolus and more abundant nuclear heterochromatin. We suggested2s3 that the morphology and membrane markers of HCL-V cells were intermediate between those of HCL and B-prolymphocytic leukemia (B-PLL).
There has been little information on the clinical course and response to treatment in HCL-V. Preliminary data suggest that HCL-V patients do not respond well to the treatments useful in typical HCL.4.5 Thus, it is important to define more precisely the diagnostic criteria of this variant form. We describe here the clinical and laboratory features of a relatively large series of HCL-V patients and compare this information with that of other B-cell leukemias evolving with splenomegaly: HCL, B-PLL, and splenic lymphoma with circulating villous lymphocytes (SLVL).3
MATERIALS AND METHODS
Since 1982 we have reviewed diagnostic material from 17 patients (10 males and 7 females) with HCL-V ( Table 1) . The diagnosis was made on morphologic, immunologic, and histologic grounds. The clinical features of HCL-V were compared with a series of 44 cases of HCL studied in our laboratory, and for the comparison with SLVL and B-PLL we used our own published
The cell morphology was studied by light microscopy on peripheral blood and bone marrow films stained with May GriinwaldGiemsa. Demonstration of tartrate-resistant acid phosphatase (TRAP) was performed in accordance with the recommendations of the International Committee for Standardization in Hematology. ' A series of monoclonal antibodies (MoAbs) were tested on peripheral blood mononuclear cell suspensions obtained by density gradient separation with Lymphoprep (Nycomed, Oslo, Norway) by indirect immunofluorescence (IF) and/or on cytospin-made slides by immunoperoxidase (IP) staining. The following histologic material was available for review: bone marrow trephine (seven cases) and spleen histology (seven cases). In four patients the splenectomy was performed after treatment with chemotherapy, splenic irradiation, or a-interferon (a-IFN).
RESULTS

Clinical features.
These are summarized in Table 1 . The median age at diagnosis was 69 years. The presenting symptoms included splenic discomfort, weakness, and weight loss; in five patients the diagnosis was incidental. One patient was referred after an attack of gout and congestive cardiac failure.
Physical findings were as follows: splenomegaly in 15 of 16 patients; hepatomegaly in 5, and minimal lymphadenopathy in 2. The median white blood cell count was 116 x 109/L and the median monocyte count 2 x 109/L. Mild anemia was present in 8 patients, and 7 also had thrombocytopenia. None of the patients had a detectable serum paraprotein. Light microscopy examination of peripheral blood cells showed a relatively homogenous appearance with a cell size 1.5 to 2.5 times that of a red blood cell. The cells had a moderate amount of visible cytoplasm in five cases and more abundant in the others (Figs 1 and 2) . The nucleus was round and centrally located; in three cases some cells had Morphology. Table 2 . B-Cell Membrane Markers in HCL-V a deep nuclear cleft. The chromatin was condensed in 14 cases and it was slightly more open in the remaining three. All but one case had a variable number of binucleated cells (Fig 3) . and in eight of them large cells with hyperchromatic appearance were seen. The nucleolus was always visible in about 70% of cells and was often single, round, and usually prominent. The cytoplasm was slightly basophilic with fine hairy projections in almost all the cells. These projections were irregular with an uneven distribution all around the membrane with lace-like projections. Ultrastructural morphology confirmed the features described (Fig 4) . In none of the five cases studied were ribosome lamella complexes. as Membrane marker studies showed a B-cell phenotype in all cases (Table 2) with a low percentage of T cells assessed by E rosettes, CD2, CD3, and CDS; the leukemic cells were CDS-.
Cells from all but two of the 17 patients expressed Ig with light chain isotype restriction. Fluorescence intensity was moderate to strong. Two cases were Ig negative by membrane and cytoplasmic staining with all reagents tested. Rearrangement of the Ig heavy and light chain genes was demonstrated in one of these two Ig negative cases (data not shown). Membrane Ig staining was negative in another two cases, but these were Ig positive by cytoplasmic staining. The cells in 1 1 of 14 cases positive for heavy chains expressed IgG alone (eight cases) or in association with IgA or IgM (three Immunophenotype. cases). In the three remaining cases the cells expressed IgA (two cases) or IgM (one case).
Reactivity with MoAbs restricted to certain stages of B differentiation such as CDIO, CD21, CD23, and CD38 was absent or rarely observed. Of the cases tested, BUI 1 was positive in two thirds and CDl IC (LeuMS) in all of them. In contrast with findings in classical HCL, the MoAb anti-TAC (CD25) and anti-HC2 were always negative ( Table 2) .
In the five patients who had a bone marrow aspirate reviewed, this was easily obtained. The films showed normal cellularity and infiltration by lymphoid cells with similar morphology to the peripheral blood cells.
Bone marrow trephine biopsies showed an interstitial pattern of infiltration in six cases and a diffuse nodular Histology. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From pattern in one. In three cases the cells formed clumps without spaces in between, and in the remainder some cells were arranged in clumps and others were surrounded by perinuclear spaces. In all the sections the cells showed condensed chromatin and visible nucleoli. Reticulin fibers were slightly to moderately increased.
The spleen sections showed red pulp expansion with extensive lymphoid infiltration of the red pulp and the sinuses and atrophy of the white pulp ( Figs 5 and 6 ); in three cases in which there was evidence of residual white pulp, this was infiltrated by leukemic cells. In two cases a degree of sclerosis was present, but both of them had been treated with chemotherapy. Expansion of sinusoids and formation of blood lakes was seen in only one case. The cells were packed, had a small amount of cytoplasm and elongated nucleus with condensed chromatin and nucleoli.
Data of the 13 treated patients are summarized in Table 3 . All seven who received a-IFN (administered at a dose of 3 megaunits daily or every other day for at least 2 months) did not respond. One patient continued treatment for over 1 year and experienced some benefit, but hairy cells persisted in the peripheral blood. Few patients had a partial or transient response to splenectomy, splenic irradiation, or chlorambucil. Of three patients treated with Z'deoxycoformycin, a partial response was seen in two, both of whom had been resistant to a-IFN. In one of them this response has been maintained for over 1 year with monthly injections of Z'deoxycoformycin. Despite the poor response to treatment, 15 HCL-V patients are alive with a median time of 4 years from diagnosis (range 7 months to 1 1 years). Only two serious complications were recorded: one patient developed immune thrombocytopenic purpura and a second pneumonia. One patient has been observed without treatment for 18 months from diagnosis and is well with stable disease. Two patients died shortly after diagnosis; one Response to treatment.
was 92 years old and the other presented with congestive cardiac failure.
DISCUSSION
Since the variant form of HCL was first recognized, a total of eight cases had been reported.'-2*4-s*'0 We describe here a series of 17 cases of HCL-V and compare them with HCL and SLVL, two other B-cell disorders with hairy or villous lymphocytes, to define better this disease entity. The findings in our patients are similar to those previously reported: high leukocyte counts without monocytopenia or other significant cytopenias, splenomegaly, and an easily aspirable bone marrow with lymphoid cell infiltration. These and the lack of male preponderance represent features with major clinical differences from typical HCL. A diagnosis of HCL-V, suspected on these grounds, could be confirmed by morphologic and immunophenotypic analysis of peripheral blood samples.
The B-cell phenotype of circulating HCL-V cells has several differences from findings in typical hairy cells. In the majority of cases the predominant Smlg is IgG, and this differs from findings in other B-cell disorders where IgM is the most frequent isotype ( Table 4 ). The expression of membrane light chains is also different in HCL-V where X light chains predominate and contrast with findings in HCL and other B-cell disorders ( Table 4) . This pattern of Ig expression suggests that the B cells of HCL-V are more mature.
HCL-V cells are also different from typical hairy cells in being unreactive with the MoAb anti-HC2" and anti-TAC (CD25). Although reactivity with LeuMS was demonstrated in all cases, the density of the CDI IC antigen was low, as in some it was positive by IP and not by membrane staining. Similar to HCL, but distinct from B-PLL and SLVL. the HCL-V cells were negative with the MoAb L3O.l' Another Table 5 ) .
On morphologic grounds, as confirmed by morphometric studies by electron micro~copy,'~ the variant hairy cells are slightly smaller than typical hairy cells and have a more rounded nucleus with a visible nucleolus, as seen in prolymphocytes. Another distinctive feature of HCL-V was the frequent presence of binucleated and hyperchromatic cells. In contrast to HCL, TRAP reactivity" is not a feature of HCL-V, although in some of the reported cases TRAP was sometimes demonstrated.
HCL-V can also be distinguished from classical HCL on histologic grounds, chiefly in the pattern of bone marrow infiltration and the lack of the characteristic fibrosis seen in HCL. On the other hand, the pattern of infiltration of the spleen was closer to that of HCL with red pulp expansion with lymphoid infiltration, although three HCL-V cases showed some infiltration of the cells into the white pulp. Furthermore, the cytology of the splenic cells was similar in many respects to that of B-PLL, except that in the latter the predominant infiltration is in the white pulp.
Splenic lymphoma with circulating villous lymphocytes' is another B-cell disorder to consider in the differential diagnosis of HCL-V. In addition to some phenotypic features (Table S) , HCL-V can be distinguished from SLVL by its morphology (cells are larger with prominent nucleoli in HCL-V), the pattern of splenic infiltration, and the absence of a demonstrable paraprotein in the serum. The latter has been reported in one case of HCL-VI and is a common finding in SLVL. 3 The early descriptions of HCL-V suggested that the patients were resistant or only partial responders to splenectomy,'.' splenic irradiation, and In contrast to HCL, which can be treated effectively with a-IFN,I6 HCL-V appears to be resistant to this Our series (Table 3 ) has extended these observations. All seven patients treated with a-IFN showed no objective response. This may relate to a low number of a-IFN receptors, which are abundant in typical HCL." This was the case in 1 of the 2 patients reported by Lehn et a14; thus, lack of receptors alone may not explain the poor response to a-IFN in this disease. Two out of three patients had a partial response to 2'deoxycoformycin. This is similar to the report by Foon et a1" of two patients responding to 2'deoxycoformycin after failure of a-IFN, one of them with the features of HCL-V, as described by Giardina et aL5 Despite the poor response to treatment, HCL-V usually has a benign clinical course. Fourteen patients in our series are alive and well with a median survival greater than 4 years.
Our study confirms the importance of morphology, histology, and markers to define disease entities." In this way the natural history of some of the chronic leukemias evolving with splenomegaly can be better defined, as well as the optimal treatment approach. We have established here that HCL-V is a distinctive B-cell lymphoproliferative disorder with a white blood cell count consistently higher than in typical HCL cells with intermediate morphology between hairy cells and prolymphocytes; TRAP negativity; a mature B phenotype with lack of expression of HC2, CD24, and CD25; predominant red pulp involvement of the spleen; no response to a-IFN; and overall good survival.
